Leading Lobbying Practices to Drive 1.5C Policy Action

This guidance is a resource for investors to use when discussing responsible purchasing and contracting issues with companies.

On January 18 and 19, 2023, ICCR hosted a Just Transition Roundtable to provide a forum for utility companies and a broad range of stakeholders to share their perspectives on a just and equitable energy transition. This report aims to document lessons learned through hosting the Roundtable as well as needs and recommendations shared by participants.

The filing of shareholder proposals is an important tool investors can use to catalyze environmental and social change at corporations. During the 2023 proxy season, ICCR members filed 454 resolutions at nearly 200 publicly traded companies on a range of issues. What follows is a brief recap of the outcomes of these proposals, as reported to ICCR. For the […]

ICCR’s guide How to File a Shareholder Resolution offers a visual illustration of the process, a detailed explanation of filing requirements, tips on writing a successful resolution, strategies for boosting your resolution’s vote, what to expect when attending an AGM, and how to keep the momentum going after filing. Updated November 28, 2023.

A new report published by the Access to Medicine Foundation. It is becoming increasingly clear that releasing antibiotic waste into the environment can drive antimicrobial resistance (AMR). In helping to curb this rapidly rising global health threat, pharmaceutical companies can ensure the production of their lifesaving antibiotics does not inadvertently contribute to drug resistance. A new […]

ICCR’s 2021-2022 Annual Report provides a twelve-month recap of our members’ successes and impacts, and includes our financials, current staff, and board.

This guide presents ICCR member-sponsored resolutions — both as lead- and co-filer — for 2023 corporate proxies, as of February 16, 2023.You can listen to the webinar recording at this link.

When pharmaceutical companies set targets for executive performance, and base the amount of their compensation on meeting those targets, they often use profit metrics that are not based on Generally-Accepted Accounting Principles (like “Adjusted Earnings Per Share”) which routinely filter out legal settlement costs and fines from the end result. By excluding the $5 billion […]

This report summarizes the work of the Investors for Opioid Accountability (IOA) from July 1, 2017 to July 31, 2019. The IOA is a diverse global coalition of 57 members representing public, faith-based, labor, and sustainability funds, as well as investment managers, with $4 trillion in collective assets under management and advisement. The report covers […]